Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00722111 · ClinicalTrials.gov registry record · NA
Exercise for Swallowing Problems After Stroke
A NA study, sponsored by VA Office of Research and Development.
- Completed
- Registry status
- NA
- Development phase
- 83
- Enrollment target
NCT00722111: Completed NA study, sponsored by VA Office of Research and Development.
NCT00722111 is a NA study that has completed, run by VA Office of Research and Development. The registered enrollment target is 83 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (94% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00722111, a NA study, has completed, sponsored by VA Office of Research and Development.
- COMPLETED
- Registry status
- NA
- Development phase
- 83 participants
- Enrollment target
Study Summary
The purpose of this study is to determine whether stroke patients with swallowing problems will show greater swallowing improvement with intense oral exercise than subjects who perform either a low intensity oral exercise or a sham exercise.
Primary Outcome
Tongue Strength
Interventions
- DEVICE lingual press
- BEHAVIORAL effortful swallowing
- BEHAVIORAL natural swallowing
- BEHAVIORAL non-oral sham (control) exercise
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 83 participants |
| Start Date | 2011-02 |
| Est. Completion | 2012-06 |
| Phase | NA |
What the finished NCT00722111 record still lists
NCT00722111 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 83 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (94% lower).
The record links to 0 conditions, and to 4 interventions - of which lingual press is the first listed.
NCT00722111 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT00722111 about?
NCT00722111 is a clinical study titled "Exercise for Swallowing Problems After Stroke". The purpose of this study is to determine whether stroke patients with swallowing problems will show greater swallowing improvement with intense oral exercise than subjects who perform either a low intensity oral exercise or a sham exercise.
What is the current status of trial NCT00722111?
This trial is currently completed. It is a NA study. The enrollment target is 83 participants. The study started on 2011-02. Estimated completion is 2012-06.
What interventions are being tested in trial NCT00722111?
The interventions under investigation include: lingual press (DEVICE), effortful swallowing (BEHAVIORAL), natural swallowing (BEHAVIORAL), non-oral sham (control) exercise (BEHAVIORAL).
Who is sponsoring clinical trial NCT00722111?
This trial is sponsored by VA Office of Research and Development, which has 1,668 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT00722111's enrollment target sits among peer trials
83 990th of 2000 higher than 1,011 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02974647 · 83 participants · Phase 2
Study of Ruxolitinib in Relapsed or Refractory T or NK Cell Lymphoma
- NCT03919292 · 83 participants · Phase 1
Neratinib + Valproate in Advanced Solid Tumors, w/Expansion Cohort in Ras-Mutated Ca
- NCT04626674 · 83 participants · Phase 1
A Gene Transfer Therapy Study to Evaluate the Safety of and Expression From Delandistrogene Moxeparvovec (SRP-9001) in Participants With Duchenne Muscular Dystrophy (DMD)
- NCT05277168 · 83 participants · Phase 1
A Trial TO Evaluate THE Safety, Tolerability, Pharmacokinetics, AND Efficacy OF Shr-a1904 IN Subjects With Advanced Solid Tumors
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia